Holger Bronger

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Binding Protein

Human Immunodeficiency Virus

Top Venues

British journal of cancer

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fabian Stögbauer, Barbara Geß, Christine E Brambs, Manuela Lautizi, Tim Kacprowski, Iordanis Ourailidis, Holger Bronger, Marion Kiechle, Aurelia Noske, Gisela Keller, Moritz Jesinghaus, Christopher Poremba, Wilko Weichert, Melanie Boxberg
Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients. Cancers 15 (15) (2023)
Gökhan Güner, Marlene Aßfalg, Kai Zhao, Tobias Dreyer, Shibojyoti Lahiri, Yun Lo, Bianca Ionela Slivinschi, Axel Imhof, Georg Jocher, Laura Strohm, Christian Behrends, Dieter Langosch, Holger Bronger, Christopher Nimsky, Jörg Walter Bartsch, Stanley R Riddell, Harald Steiner, Stefan F Lichtenthaler
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity. EMBO molecular medicine 14 (10) (2022)
Stefanie Seitz, Tobias F Dreyer, Christoph Stange, Katja Steiger, Rosalinde Bräuer, Leandra Scheutz, Gabriele Multhoff, Wilko Weichert, Marion Kiechle, Viktor Magdolen, Holger Bronger
CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer. British journal of cancer 126 (10) (2022)